图书馆订阅： Guest
肿瘤形成评论综述™

每年出版 4 期

ISSN 打印: 0893-9675

ISSN 在线: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

获得访问权(open in a new tab)
更多的
购买 $50.00(open in a new tab) 检查订阅 下载MARC(open in a new tab) 获取权限(open in a new tab)

Targeting PI3 Kinase/AKT/mTOR Signaling in Cancer

卷 17, 册 1, 2012, pp. 69-95
DOI: 10.1615/CritRevOncog.v17.i1.60
Get accessGet access
Karen Sheppard
Division of Cancer Research, Peter MacCallum Cancer Centre , Department of Biochemistry and Molecular Biology
Kathryn M Kinross
Division of Cancer Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Benjamin Solomon
Division of Cancer Research, Division of Cancer Medicine, and Sir Peter MacCallum Department of Oncology, and the Monash University, Clayton, Australia
Richard B. Pearson
Division of Cancer Research, Department of Biochemistry and Molecular Biology, Sir Peter MacCallum Department of Oncology, and the Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia
Wayne A. Phillips
Division of Cancer Research, Division of Cancer Surgery, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, and the Department of Surgery (SVH), University of Melbourne, Parkville, Australia

摘要

The phosphatidylinositol 3 kinase (PI3K) pathway is one of the major pathways modulating cell growth, proliferation, metabolism, survival, and angiogenesis. Hyperactivation of this pathway is one of the most frequent occurrences in human cancer and is thus an obvious target for treatment of this disease. Currently there are 26 novel compounds targeting the PI3K pathway being assessed in more than 150 cancer-related clinical trials. Although this pathway is involved in many vital biologic functions, data emanating from these clinical trials indicate that these drugs are well tolerated. This review outlines the interaction of the PI3K pathway with other signaling cascades, highlights mechanisms involved in hyperactivation, discusses current therapeutics in cancer-related clinical trials that target this pathway, and, based on preclinical data, discusses possible leads on patient selection and combinational therapy, including targeting multiple components of the associated signaling network.

键词: phosphatidylinositol 3 kinase, anticancer drugs, targeted therapeutics, kinase inhibitors, combinational therapy, clinical trials
对本文的引用

  1. Striano Pasquale, Zara Federico, Mutations in mTOR pathway linked to megalencephaly syndromes, Nature Reviews Neurology, 8, 10, 2012. Crossref

  2. Britschgi Adrian, Andraos Rita, Brinkhaus Heike, Klebba Ina, Romanet Vincent, Müller Urs, Murakami Masato, Radimerski Thomas, Bentires-Alj Mohamed, JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer, Cancer Cell, 22, 6, 2012. Crossref

  3. Somnay Yash, Simon Kevin, Harrison April D., Kunnimalaiyaan Selvi, Chen Herbert, Kunnimalaiyaan Muthusamy, Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro, Anti-Cancer Drugs, 24, 1, 2013. Crossref

  4. Kannan Arun, Huang Weishan, Huang Fei, August Avery, Signal transduction via the T cell antigen receptor in naïve and effector/memory T cells, The International Journal of Biochemistry & Cell Biology, 44, 12, 2012. Crossref

  5. Galat Andrzej, Functional diversity and pharmacological profiles of the FKBPs and their complexes with small natural ligands, Cellular and Molecular Life Sciences, 70, 18, 2013. Crossref

  6. Montemurro Filippo, Rossi Valentina, Geuna Elena, Valabrega Giorgio, Martinello Rossella, Milani Andrea, Aglietta Massimo, Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer, Expert Opinion on Pharmacotherapy, 13, 15, 2012. Crossref

  7. Dufour Julie, Viennois Emilie, De Boussac Hugues, Baron Silvère, Lobaccaro Jean-Marc, Oxysterol receptors, AKT and prostate cancer, Current Opinion in Pharmacology, 12, 6, 2012. Crossref

  8. Hannan K.M., Sanij E., Rothblum L.I., Hannan R.D., Pearson R.B., Dysregulation of RNA polymerase I transcription during disease, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1829, 3-4, 2013. Crossref

  9. Fam HK, Caught in the AKT: identification of ade novopathway in MCAP and MPPH and its therapeutic implications, Clinical Genetics, 82, 6, 2012. Crossref

  10. Suman Suman, Kurisetty Vittal, Das Trinath P., Vadodkar Aditi, Ramos Gabriel, Lakshmanaswamy Rajkumar, Damodaran Chendil, Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells, Molecular Carcinogenesis, 53, S1, 2014. Crossref

  11. Miyake Hideaki, Harada Ken-ichi, Kumano Masafumi, Fujisawa Masato, Assessment of efficacy, safety and quality of life of 55 patients with metastatic renal cell carcinoma treated with temsirolimus: a single-center experience in Japan, International Journal of Clinical Oncology, 19, 4, 2014. Crossref

  12. Nishikawa Masatomo, Miyake Hideaki, Harada Ken-ichi, Fujisawa Masato, Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy, Urologic Oncology: Seminars and Original Investigations, 32, 1, 2014. Crossref

  13. Wan J, Liu T, Mei L, Li J, Gong K, Yu C, Li W, Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling, British Journal of Cancer, 109, 2, 2013. Crossref

  14. Matsuda Satoru, Kobayashi Mayumi, Kitagishi Yasuko, Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease, ISRN Endocrinology, 2013, 2013. Crossref

  15. Schmitt Céline, Voegelin Manon, Marin Aurélie, Schmitt Marjorie, Schegg Fabienne, Hénon Philippe, Guenot Dominique, Tarnus Céline, Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy, Bioorganic & Medicinal Chemistry, 21, 7, 2013. Crossref

  16. Romano Gaetano, The Role of the Dysfunctional Akt-Related Pathway in Cancer: Establishment and Maintenance of a Malignant Cell Phenotype, Resistance to Therapy, and Future Strategies for Drug Development, Scientifica, 2013, 2013. Crossref

  17. Chen Zhiheng, Yang Li, Liu Yong, Tang Anliu, Li Xin, Zhang Juan, Yang Zuocheng, LY294002 and Rapamycin promote coxsackievirus-induced cytopathic effect and apoptosis via inhibition of PI3K/AKT/mTOR signaling pathway, Molecular and Cellular Biochemistry, 385, 1-2, 2014. Crossref

  18. Voss Jesse S., Holtegaard Leonard M., Kerr Sarah E., Fritcher Emily G. Barr, Roberts Lewis R., Gores Gregory J., Zhang Jun, Highsmith W. Edward, Halling Kevin C., Kipp Benjamin R., Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions, Human Pathology, 44, 7, 2013. Crossref

  19. Owens Cormac, Abbott Lesleigh S., Gupta Abha A., Optimal Management of Ewing Sarcoma Family of Tumors: Recent Developments in Systemic Therapy, Pediatric Drugs, 15, 6, 2013. Crossref

  20. Uihlein Lily C., Liang Marilyn G., Fishman Steven J., Alomari Ahmad I., Mulliken John B., Capillary-Venous Malformation in the Lower Limb, Pediatric Dermatology, 30, 5, 2013. Crossref

  21. Devlin Jennifer R., Hannan Katherine M., Ng Pui Y., Bywater Megan J., Shortt Jake, Cullinane Carleen, McArthur Grant A., Johnstone Ricky W., Hannan Ross D., Pearson Richard B., AKT signalling is required for ribosomal RNA synthesis and progression of Eμ-MycB-cell lymphomain vivo, FEBS Journal, 280, 21, 2013. Crossref

  22. Kilic-Eren Mehtap, Boylu Tulin, Tabor Vedrana, Targeting PI3K/Akt represses Hypoxia inducible factor-1α activation and sensitizes Rhabdomyosarcoma and Ewing’s sarcoma cells for apoptosis, Cancer Cell International, 13, 1, 2013. Crossref

  23. Choi Hyeong Sim, Jeong Eun-Hui, Lee Tae-Gul, Kim Seo Yun, Kim Hye-Ryoun, Kim Cheol Hyeon, Autophagy Inhibition with Monensin Enhances Cell Cycle Arrest and Apoptosis Induced by mTOR or Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cells, Tuberculosis and Respiratory Diseases, 75, 1, 2013. Crossref

  24. Nishikawa Masatomo, Miyake Hideaki, Harada Ken-ichi, Fujisawa Masato, Expression level of phosphorylated-4E-binding protein 1 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with mammalian target of rapamycin inhibitors, Medical Oncology, 31, 1, 2014. Crossref

  25. Parrales Alejandro, López Edith, Lee-Rivera Irene, López-Colomé Ana María, ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation, Cellular Signalling, 25, 4, 2013. Crossref

  26. Mok Ka Wai, Mruk Dolores D., Cheng C. Yan, , 301, 2013. Crossref

  27. Sheppard Karen E., Cullinane Carleen, Hannan Katherine M., Wall Meaghan, Chan Joanna, Barber Frances, Foo Jung, Cameron Donald, Neilsen Amelia, Ng Pui, Ellul Jason, Kleinschmidt Margarete, Kinross Kathryn M., Bowtell David D., Christensen James G., Hicks Rodney J., Johnstone Ricky W., McArthur Grant A., Hannan Ross D., Phillips Wayne A., Pearson Richard B., Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors, European Journal of Cancer, 49, 18, 2013. Crossref

  28. Schouppe Elio, Van Overmeire Eva, Laoui Damya, Keirsse Jiri, Van Ginderachter Jo A., Modulation of CD8+ T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells, Immunobiology, 218, 11, 2013. Crossref

  29. Arbini A A, Guerra F, Greco M, Marra E, Gandee L, Xiao G, Lotan Y, Gasparre G, Hsieh J-T, Moro L, Mitochondrial DNA depletion sensitizes cancer cells to PARP inhibitors by translational and post-translational repression of BRCA2, Oncogenesis, 2, 12, 2013. Crossref

  30. Hong Da Hye, Choi Il-Whan, Son Youn Kyoung, Kim Dae-Joong, Na Sung Hun, Jung Won-Kyo, Yoon Young Wook, Park Won Sun, The effect of PI3 kinase inhibitor LY294002 on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells, Life Sciences, 92, 17-19, 2013. Crossref

  31. Koren Shany, Bentires-Alj Mohamed, Mouse models ofPIK3CAmutations: one mutation initiates heterogeneous mammary tumors, FEBS Journal, 280, 12, 2013. Crossref

  32. Loayza-Puch Fabricio, Drost Jarno, Rooijers Koos, Lopes Rui, Elkon Ran, Agami Reuven, p53 induces transcriptional and translational programs to suppress cell proliferation and growth, Genome Biology, 14, 4, 2013. Crossref

  33. Wang Feng-Ze, Peng-Jiao , Yang Na-Na, Chuang-Yuan , Zhao Ya-Li, Liu Qiang-Qiang, Fei Hong-Rong, Zhang Ji-Guo, PF-04691502 triggers cell cycle arrest, apoptosis and inhibits the angiogenesis in hepatocellular carcinoma cells, Toxicology Letters, 220, 2, 2013. Crossref

  34. Tran Thang N., Brettingham-Moore Kate, Duong Cuong P., Mitchell Catherine, Clemons Nicholas J., Phillips Wayne A., Molecular changes in the phosphatidylinositide 3-kinase (PI3K) pathway are common in gastric cancer, Journal of Surgical Oncology, 108, 2, 2013. Crossref

  35. Zardavas Dimitrios, Phillips Wayne A, Loi Sherene, PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data, Breast Cancer Research, 16, 1, 2014. Crossref

  36. Zhu Liping, Luo Qingqiong, Bi Jianjun, Ding Jieying, Ge Shengfang, Chen Fuxiang, Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo, Chemico-Biological Interactions, 224, 2014. Crossref

  37. Chimal-Ramírez G. K., Espinoza-Sánchez N. A., Fuentes-Pananá E. M., Protumor Activities of the Immune Response: Insights in the Mechanisms of Immunological Shift, Oncotraining, and Oncopromotion, Journal of Oncology, 2013, 2013. Crossref

  38. Li J., You T., Jing J., MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway, Cell Proliferation, 47, 2, 2014. Crossref

  39. Rangwala Reshma, Chang Yunyoung C, Hu Janice, Algazy Kenneth M, Evans Tracey L, Fecher Leslie A, Schuchter Lynn M, Torigian Drew A, Panosian Jeffrey T, Troxel Andrea B, Tan Kay-See, Heitjan Daniel F, DeMichele Angela M, Vaughn David J, Redlinger Maryann, Alavi Abass, Kaiser Jonathon, Pontiggia Laura, Davis Lisa E, O’Dwyer Peter J, Amaravadi Ravi K, Combined MTOR and autophagy inhibition, Autophagy, 10, 8, 2014. Crossref

  40. Kitagishi Yasuko, Kobayashi Mayumi, Kikuta Kanae, Matsuda Satoru, Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses, Depression Research and Treatment, 2012, 2012. Crossref

  41. Rahman Nazneen, Realizing the promise of cancer predisposition genes, Nature, 505, 7483, 2014. Crossref

  42. Quin Jaclyn E., Devlin Jennifer R., Cameron Donald, Hannan Kate M., Pearson Richard B., Hannan Ross D., Targeting the nucleolus for cancer intervention, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1842, 6, 2014. Crossref

  43. Dentelli Patrizia, Traversa Matteo, Rosso Arturo, Togliatto Gabriele, Olgasi Crisitna, Marchiò Caterina, Provero Paolo, Lembo Antonio, Bon Giulia, Annaratone Laura, Sapino Anna, Falcioni Rita, Brizzi Maria, miR-221/222 control luminal breast cancer tumor progression by regulating different targets, Cell Cycle, 13, 11, 2014. Crossref

  44. Vacas Eva, Muñoz-Moreno Laura, Fernández-Martínez Ana B., Bajo Ana M., Sánchez-Chapado Manuel, Prieto Juan C., Carmena María J., Signalling pathways involved in antitumoral effects of VIP in human renal cell carcinoma A498 cells: VIP induction of p53 expression, The International Journal of Biochemistry & Cell Biology, 53, 2014. Crossref

  45. Bitanihirwe Byron K.Y., Meerang Mayura, Friess Martina, Soltermann Alex, Frischknecht Lukas, Thies Svenja, Felley-Bosco Emanuela, Tsao Ming-Sound, Allo Ghassan, de Perrot Marc, Seifert Burkhardt, Moch Holger, Stahel Rolf, Weder Walter, Opitz Isabelle, PI3K/mTOR Signaling in Mesothelioma Patients Treated with Induction Chemotherapy Followed by Extrapleural Pneumonectomy, Journal of Thoracic Oncology, 9, 2, 2014. Crossref

  46. Zanini Sara, Giovinazzo Francesco, Alaimo Daniele, Lawrence Ben, Pfragner Roswitha, Bassi Claudio, Modlin Irvin, Kidd Mark, GNA15 expression in small intestinal neuroendocrine neoplasia: Functional and signalling pathway analyses, Cellular Signalling, 27, 5, 2015. Crossref

  47. Underwood Timothy J, Hayden Annette L, Derouet Mathieu, Garcia Edwin, Noble Fergus, White Michael J, Thirdborough Steve, Mead Abbie, Clemons Nicholas, Mellone Massimiliano, Uzoho Chudy, Primrose John N, Blaydes Jeremy P, Thomas Gareth J, Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinoma, The Journal of Pathology, 235, 3, 2015. Crossref

  48. Maione Federica, Oliaro-Bosso Simonetta, Meda Claudia, Di Nicolantonio Federica, Bussolino Federico, Balliano Gianni, Viola Franca, Giraudo Enrico, The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination, Scientific Reports, 5, 1, 2015. Crossref

  49. Gao Lei, Wang Yan, Xu Zhen, Li Xiaorui, Wu Jingjun, Liu Shumin, Chu Peng, Sun Zhengwu, Sun Bin, Lin Yuan, Peng Jinyong, Han Guozhu, Wang Shisheng, Tang Zeyao, SZC017, a novel oleanolic acid derivative, induces apoptosis and autophagy in human breast cancer cells, Apoptosis, 20, 12, 2015. Crossref

  50. Alifieris Constantinos, Trafalis Dimitrios T., Glioblastoma multiforme: Pathogenesis and treatment, Pharmacology & Therapeutics, 152, 2015. Crossref

  51. Park Hyojin, Lee Sungwoon, Shrestha Pravesh, Kim Jihye, Park Jeong Ae, Ko Yeongrim, Ban Young Ho, Park Dae-Young, Ha Sang-Jun, Koh Gou Young, Hong Victor Sukbong, Mochizuki Naoki, Kim Young-Myeong, Lee Weontae, Kwon Young-Guen, AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation, Journal of Cell Biology, 211, 3, 2015. Crossref

  52. Zhao Yue, Wang Xiaoping, Sun Yang, Zhou Yuxin, Yin Yuehan, Ding Youxiang, Li Zhiyu, Guo Qinglong, Lu Na, LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells, Apoptosis, 20, 9, 2015. Crossref

  53. Qian Long, Shi Jiahai, Zhang Chi, Lu Jiawei, Lu Xiaoning, Wu Kunpeng, Yang Chen, Yan Daliang, Zhang Chao, You Qingsheng, Liu Xiaojuan, Downregulation of RACK1 is associated with cardiomyocyte apoptosis after myocardial ischemia/reperfusion injury in adult rats, In Vitro Cellular & Developmental Biology - Animal, 52, 3, 2016. Crossref

  54. Bernardi Maria-Pia, Ngan Samuel Y, Michael Michael, Lynch A Craig, Heriot Alexander G, Ramsay Robert G, Phillips Wayne A, Molecular biology of anal squamous cell carcinoma: implications for future research and clinical intervention, The Lancet Oncology, 16, 16, 2015. Crossref

  55. TOKUHIRA NANA, KITAGISHI YASUKO, SUZUKI MIHO, MINAMI AKARI, NAKANISHI ATSUKO, ONO YUNA, KOBAYASHI KEIKO, MATSUDA SATORU, OGURA YASUNORI, PI3K/AKT/PTEN pathway as a target for Crohn’s disease therapy (Review), International Journal of Molecular Medicine, 35, 1, 2015. Crossref

  56. Guo Lixia, Wang Jingyu, Yang Ping, Lu Qiang, Zhang Ting, Yang Yanan, MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation, IUBMB Life, 67, 9, 2015. Crossref

  57. Lee Seung Hwan, Yumnam Silvia, Hong Gyeong Eun, Raha Suchismita, Venkatarame Gowda Saralamma Venu, Lee Ho Jeong, Heo Jeong Doo, Lee Sang Joon, Lee Won-Sup, Kim Eun-Hee, Park Hyeon Soo, Kim Gon Sup, Flavonoids of KoreanCitrus aurantiumL. Induce Apoptosis via Intrinsic Pathway in Human Hepatoblastoma HepG2 Cells, Phytotherapy Research, 29, 12, 2015. Crossref

  58. Nishikawa Masatomo, Miyake Hideaki, Behnsawy Hosny M., Fujisawa Masato, Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder, Urologic Oncology: Seminars and Original Investigations, 33, 4, 2015. Crossref

  59. Liu Zhen, Liu Shushang, Zheng Gaozan, Yang Jianjun, Hong Liu, Sun Li, Fan Daiming, Zhang Hongwei, Feng Fan, Clinicopathological features and prognosis of coexistence of gastric gastrointestinal stromal tumor and gastric cancer, Medicine, 95, 45, 2016. Crossref

  60. Hamilton Gerhard, Comparison of Intracellular Stress Response of NCI-H526 Small Cell Lung Cancer (SCLC) Cells to Platinum(II) Cisplatin and Platinum(IV) Oxoplatin, Cancers, 6, 3, 2014. Crossref

  61. Woo Young, Seo Hye-Jin, McIntyre Roger, Bahk Won-Myong, Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review, International Journal of Molecular Sciences, 17, 1, 2016. Crossref

  62. Liu Zhen, Tian Yangzi, Liu Shushang, Xu Guanghui, Guo Man, Lian Xiao, Fan Daiming, Zhang Hongwei, Feng Fan, Clinicopathological feature and prognosis of primary hepatic gastrointestinal stromal tumor, Cancer Medicine, 5, 9, 2016. Crossref

  63. Bossi Paolo, Alfieri Salvatore, Investigational drugs for head and neck cancer, Expert Opinion on Investigational Drugs, 25, 7, 2016. Crossref

  64. Poovathingal Suresh Kumar, Kravchenko-Balasha Nataly, Shin Young Shik, Levine Raphael David, Heath James R., Critical Points in Tumorigenesis: A Carcinogen-Initiated Phase Transition Analyzed via Single-Cell Proteomics, Small, 12, 11, 2016. Crossref

  65. Qi Wei-Xiang, Huang Yu-Jing, Yao Yang, Shen Zan, Min Da-Liu, de Mello Ramon Andrade, Incidence and Risk of Treatment-Related Mortality with mTOR Inhibitors Everolimus and Temsirolimus in Cancer Patients: A Meta-Analysis, PLoS ONE, 8, 6, 2013. Crossref

  66. Kurdi Ammar, De Meyer Guido R. Y., Martinet Wim, Potential therapeutic effects of mTOR inhibition in atherosclerosis, British Journal of Clinical Pharmacology, 82, 5, 2016. Crossref

  67. Machado Vera A., Peixoto Daniela, Queiroz Maria João, Soares Raquel, Antiangiogenic 1-Aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas Inhibit MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines Through PI3K/Akt and MAPK/Erk Pathways, Journal of Cellular Biochemistry, 117, 12, 2016. Crossref

  68. Nakai Yasushi, Miyake Makito, Morizawa Yosuke, Hori Shunta, Tatsumi Yoshihiro, Anai Satoshi, Onishi Sayuri, Tanaka Nobumichi, Fujimoto Kiyohide, Potential biomarkers for the therapeutic efficacy of sorafenib, sunitinib and everolimus, Oncology Reports, 37, 1, 2017. Crossref

  69. Wei Zhengyu, Doria Cataldo, Liu Yuan, Targeted Therapies in the Treatment of Advanced Hepatocellular Carcinoma, Clinical Medicine Insights: Oncology, 7, 2013. Crossref

  70. Zhao Ruo-lin, He Yu-min, Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice, Journal of Ethnopharmacology, 210, 2018. Crossref

  71. XIAO WENKAI, JIANG YAJIE, MEN QIUXU, YUAN LING, HUANG ZEBO, LIU TING, LI WENHUA, LIU XIN, Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo, International Journal of Oncology, 46, 1, 2015. Crossref

  72. Lin Yu-Min, Huang Yuan-Li, Fong Yi-Chin, Tsai Chun-Hao, Chou Ming-Chih, Tang Chih-Hsin, Datta Kaustubh, Hepatocyte Growth Factor Increases Vascular Endothelial Growth Factor-A Production in Human Synovial Fibroblasts through c-Met Receptor Pathway, PLoS ONE, 7, 11, 2012. Crossref

  73. Song Yanlin, Kong Lingqi, Sun Bin, Gao Lei, Chu Peng, Ahsan Anil, Qaed Eskandar, Lin Yuan, Peng Jinyong, Ma Xiaodong, Zhang Jianbin, Wang Shisheng, Tang Zeyao, Induction of autophagy by an oleanolic acid derivative, SZC017, promotes ROS-dependent apoptosis through Akt and JAK2/STAT3 signaling pathway in human lung cancer cells, Cell Biology International, 41, 12, 2017. Crossref

  74. Zhou Lishan, Tang Jianqiao, Xiong Xiaoli, Dong Hui, Huang Juan, Zhou Shunchang, Zhang Lingling, Qin Huan, Yan Suqi, Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse, Frontiers in Pharmacology, 8, 2017. Crossref

  75. Otowa Takeshi, Maher Brion S., Aggen Steven H., McClay Joseph L., van den Oord Edwin J., Hettema John M., Brucki Sonia, Genome-Wide and Gene-Based Association Studies of Anxiety Disorders in European and African American Samples, PLoS ONE, 9, 11, 2014. Crossref

  76. Yang Bo, Zhao Yaping, Lou Chenghua, Zhao Huajun, Eupalinolide O, a novel sesquiterpene lactone from Eupatorium lindleyanum DC., induces cell cycle arrest and apoptosis in human MDA-MB-468 breast cancer cells, Oncology Reports, 36, 5, 2016. Crossref

  77. Ogawa Satoshi, Ishimura Takeshi, Miyake Hideaki, Fujisawa Masato, Expression profile of mammalian target of rapamycin-related proteins in graft biopsy specimens: Significance for predicting interstitial fibrosis after kidney transplantation, International Journal of Urology, 24, 3, 2017. Crossref

  78. Caohuy Hung, Yang Qingfeng, Eudy Yvonne, Ha Thien-An, Xu Andrew E., Glover Matthew, Frizzell Raymond A., Jozwik Catherine, Pollard Harvey B., Activation of 3-Phosphoinositide-dependent Kinase 1 (PDK1) and Serum- and Glucocorticoid-induced Protein Kinase 1 (SGK1) by Short-chain Sphingolipid C4-ceramide Rescues the Trafficking Defect of ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (ΔF508-CFTR), Journal of Biological Chemistry, 289, 52, 2014. Crossref

  79. ZHOU JIAN, SONG SHIDUO, HE SONGBING, ZHU XINGUO, ZHANG YI, YI BIN, ZHANG BING, QIN GONGZHAO, LI DECHUN, MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway, International Journal of Molecular Medicine, 33, 4, 2014. Crossref

  80. PENG RENJUN, JIANG BING, MA JIANRONG, MA ZHIMING, WAN XIN, LIU HONGWEI, CHEN ZIGUI, CHENG QUAN, CHEN RUI, Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity, Oncology Reports, 30, 5, 2013. Crossref

  81. Giacoppo Sabrina, Bramanti Placido, Mazzon Emanuela, Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson’s disease, NeuroReport, 28, 15, 2017. Crossref

  82. ZHU YALONG, ZHOU JIANHUA, JI YING, YU BAOQING, Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma, Molecular Medicine Reports, 10, 2, 2014. Crossref

  83. XU DONGSHENG, MA YONG, ZHAO BAOLEI, LI SHUAI, ZHANG YU, PAN SHANGHA, WU YAOHUA, WANG JIZHOU, WANG DAWEI, PAN HUAYANG, LIU LIANXIN, JIANG HONGCHI, Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo, Oncology Reports, 31, 5, 2014. Crossref

  84. Squadroni Michela, Tondulli Luca, Gatta Gemma, Mosconi Stefania, Beretta Giordano, Labianca Roberto, Cholangiocarcinoma, Critical Reviews in Oncology/Hematology, 116, 2017. Crossref

  85. Chruscinski Andrzej J., Singh Harvir, Chan Steven M., Utz Paul J., Porter James, Broad-Scale Phosphoprotein Profiling of Beta Adrenergic Receptor (β-AR) Signaling Reveals Novel Phosphorylation and Dephosphorylation Events, PLoS ONE, 8, 12, 2013. Crossref

  86. Rizvi Sumera, Gores Gregory J., Emerging molecular therapeutic targets for cholangiocarcinoma, Journal of Hepatology, 67, 3, 2017. Crossref

  87. Mertens Joachim C., Rizvi Sumera, Gores Gregory J., Targeting cholangiocarcinoma, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1864, 4, 2018. Crossref

  88. Wang Yang, Deng Xu, Yu Chang, Zhao Guosheng, Zhou Jing, Zhang Ge, Li Ming, Jiang Dianming, Quan Zhengxue, Zhang Yuan, Synergistic inhibitory effects of capsaicin combined with cisplatin on human osteosarcoma in culture and in xenografts, Journal of Experimental & Clinical Cancer Research, 37, 1, 2018. Crossref

  89. Xu Dong-Qing, Toyoda Hidemi, Yuan Xiao-Jun, Qi Lei, Chelakkot Vipin Shankar, Morimoto Mari, Hanaki Ryo, Kihira Kentarou, Hori Hiroki, Komada Yoshihiro, Hirayama Masahiro, Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo, Experimental Cell Research, 365, 2, 2018. Crossref

  90. Basnet Rajesh, Gong Grace Qun, Li Chenyao, Wang Ming-Wei, Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention, Acta Pharmaceutica Sinica B, 8, 5, 2018. Crossref

  91. LI SHAORU, LI YAN, HU RUILI, LI WEIHUA, QIU HAIFENG, CAI HONGHUA, WANG SHIJIN, The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells, Oncology Letters, 5, 2, 2013. Crossref

  92. S.M. Fazeela Mahaboob Begum, Chitra Kalai, Joseph Benin, Sundararajan Raji, S. Hemalatha, Gelidiella acerosa inhibits lung cancer proliferation, BMC Complementary and Alternative Medicine, 18, 1, 2018. Crossref

  93. Squires Malcolm H., Woelfel Ingrid, Cloyd Jordan M., Pawlik Timothy M., Emerging treatment options for cholangiocarcinoma, Expert Opinion on Orphan Drugs, 6, 9, 2018. Crossref

  94. Jiao Qinlian, Bi Lei, Ren Yidan, Song Shuliang, Wang Qin, Wang Yun-shan, Advances in studies of tyrosine kinase inhibitors and their acquired resistance, Molecular Cancer, 17, 1, 2018. Crossref

  95. Qian Cui-Juan, Chen Yi-Yi, Zhang Xin, Liu Fu-Qiang, Yue Ting-Ting, Ye Bei, Yao Jun, Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells, Oncology Letters, 12, 5, 2016. Crossref

  96. Marref I., Reichling C., Vendrely V., Mouillot T., Prise en charge du cancer du canal anal en 2018, Oncologie, 20, 5-6, 2018. Crossref

  97. LIU CHEN-HUI, BAO HONG-GUANG, GE YA-LI, WANG SHU-KUI, SHEN YAN, XU LI, Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer, Oncology Letters, 5, 6, 2013. Crossref

  98. Liu Jie, Liu Ranran, Wang Jie, Zhang Yonghong, Xing Siyuan, Zheng Maiqing, Cui Huanxian, Li Qinghe, Li Peng, Cui Xiaoyan, Li Wei, Zhao Guiping, Wen Jie, Exploring Genomic Variants Related to Residual Feed Intake in Local and Commercial Chickens by Whole Genomic Resequencing, Genes, 9, 2, 2018. Crossref

  99. Ohya Susumu, Kito Hiroaki, Kajikuri Junko, Ca<sup>2+</sup>-activated K<sup>+</sup> channels as cancer therapeutic targets, Folia Pharmacologica Japonica, 154, 3, 2019. Crossref

  100. Riehle Robert D., Cornea Sinziana, Degterev Alexei, Role of Phosphatidylinositol 3,4,5-Trisphosphate in Cell Signaling, in Lipid-mediated Protein Signaling, 991, 2013. Crossref

  101. Mehnert Janice M., Kaveney Amanda D., Malhotra Jyoti, Spencer Kristen, Portal Daniella, Goodin Susan, Tan Antoinette R., Aisner Joseph, Moss Rebecca A., Lin Hongxia, Bertino Joseph R., Gibbon Darlene, Doyle Laurence A., White Eileen P., Stein Mark N., A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors, Cancer Chemotherapy and Pharmacology, 84, 4, 2019. Crossref

  102. Kokabu Tetsuya, Mori Taisuke, Matsushima Hiroshi, Yoriki Kaori, Kataoka Hisashi, Tarumi Yosuke, Kitawaki Jo, Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells, Cellular Oncology, 42, 2, 2019. Crossref

  103. Borgeat Alain, Schick Carl, Votta-Velis Gina, Pharmacologic Factors: Anaesthetic Agents that May Influence Cancer Outcomes: Local Anaesthetics, Current Anesthesiology Reports, 5, 3, 2015. Crossref

  104. Noonan Janis, Murphy Brona M., Cytotoxic T Lymphocytes and Their Granzymes: An Overview, in Resistance of Cancer Cells to CTL-Mediated Immunotherapy, 7, 2015. Crossref

  105. Yu Zhijun, Ni Feng, Chen Yongmei, Zhang Jie, Cai Jing, Shi Weidong, miR-125b suppresses cell proliferation and metastasis by targeting HAX-1 in esophageal squamous cell carcinoma, Pathology - Research and Practice, 216, 2, 2020. Crossref

  106. Xu Mengjie, Xiao Feng, Wang Mengshi, Yan Tingxu, Yang Huilin, Wu Bo, Bi Kaishun, Jia Ying, Schisantherin B Improves the Pathological Manifestations of Mice Caused by Behavior Desperation in Different Ages-Depression with Cognitive Impairment, Biomolecules & Therapeutics, 27, 2, 2019. Crossref

  107. Gao Chundi, Zhuang Jing, Zhou Chao, Li Huayao, Liu Cun, Liu Lijuan, Feng Fubin, Liu Ruijuan, Sun Changgang, SNP mutation‐related genes in breast cancer for monitoring and prognosis of patients: A study based on the TCGA database, Cancer Medicine, 8, 5, 2019. Crossref

  108. Manuel-Vázquez Alba, Latorre-Fragua Raquel, Plaza-Llamas Roberto de la, Ramia José Manuel, Hepatic gastrointestinal stromal tumor: Systematic review of an exceptional location, World Journal of Meta-Analysis, 7, 5, 2019. Crossref

  109. Marat Andrea L, Haucke Volker, Phosphatidylinositol 3‐phosphates—at the interface between cell signalling and membrane traffic, The EMBO Journal, 35, 6, 2016. Crossref

  110. Gálvez-Peralta Marina, Flatten Karen S., Loegering David A., Peterson Kevin L., Schneider Paula A., Erlichman Charles, Kaufmann Scott H., Context-Dependent Antagonism between Akt Inhibitors and Topoisomerase Poisons, Molecular Pharmacology, 85, 5, 2014. Crossref

  111. Liu Qing, Wang Zhenting, Zhou Xiaohua, Tang Mingying, Tan Wei, Sun Tianshi, Wang Yifang, Deng Youwen, miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway, Journal of Physiology and Biochemistry, 76, 2, 2020. Crossref

  112. Hirsch Emilio, Gulluni Federico, Martini Miriam, Phosphoinositides in cell proliferation and metabolism, Advances in Biological Regulation, 75, 2020. Crossref

  113. Shen Cheng-Ying, Chen Li-Han, Lin Yu-Fen, Lai Liang-Chuan, Chuang Eric Y., Tsai Mong-Hsun, Mitomycin C treatment induces resistance and enhanced migration via phosphorylated Akt in aggressive lung cancer cells, Oncotarget, 7, 48, 2016. Crossref

  114. Kim Seung Tae, Lira Maruja, Deng Shibing, Lee Sujin, Park Young Suk, Lim Ho Yeong, Kang Won Ki, Mao Mao, Heo Jin Seok, Kwon Wooil, Jang Kee‑Taek, Lee Jeeyun, Park Joon Oh, PIK3CA mutation detection in metastatic biliary cancer using cell-free DNA, Oncotarget, 6, 37, 2015. Crossref

  115. Suman Suman, Das Trinath P., Sirimulla Suman, Alatassi Houda, Ankem Murali K., Damodaran Chendil, Withaferin-A suppress AKT induced tumor growth in colorectal cancer cells, Oncotarget, 7, 12, 2016. Crossref

  116. Sridharan Savitha, Basu Alakananda, Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer, International Journal of Molecular Sciences, 21, 4, 2020. Crossref

  117. Zhang Chao, Yang Lei, Geng Ya-di, An Fa-liang, Xia Yuan-zheng, Guo Chao, Luo Jian-guang, Zhang Lu-yong, Guo Qing-long, Kong Ling-yi, Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells, Oncotarget, 7, 19, 2016. Crossref

  118. Feral Anthony, Laconde Guillaume, Amblard Muriel, Masurier Nicolas, PROteolysis TArgetting Chimeras (PROTACs) Strategy Applied to Kinases: Recent Advances, Advanced Therapeutics, 3, 11, 2020. Crossref

  119. Ayestaran Iñigo, Galhoz Ana, Spiegel Elmar, Sidders Ben, Dry Jonathan R., Dondelinger Frank, Bender Andreas, McDermott Ultan, Iorio Francesco, Menden Michael P., Identification of Intrinsic Drug Resistance and Its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens, Patterns, 1, 5, 2020. Crossref

  120. Liu Yan‑Peng , Li Ling , Xu Liang , Dai E‑Nuo , Chen Wei‑Da , Cantharidin suppresses cell growth and migration, and activates autophagy in human non-small cell lung cancer cells, Oncology Letters, 2018. Crossref

  121. Cell Signaling Events, in Goodman's Medical Cell Biology, 2021. Crossref

  122. da Silva Luan Cristian, Lima Isabel Vieira de Assis, da Silva Maria Carolina Machado, Corrêa Taís Arthur, de Souza Viviane Passos, de Almeida Mauro Vieira, de Oliveira Antônio Carlos Pinheiro, Ferreira Ana Paula, A new lipophilic amino alcohol, chemically similar to compound FTY720, attenuates the pathogenesis of experimental autoimmune encephalomyelitis by PI3K/Akt pathway inhibition, International Immunopharmacology, 88, 2020. Crossref

  123. Andersen Jesper B, Thorgeirsson Snorri S, A perspective on molecular therapy in cholangiocarcinoma: present status and future directions, Hepatic Oncology, 1, 1, 2014. Crossref

  124. Márk Ágnes, Hajdu Melinda, Váradi Zsófia, Sticz Tamás Béla, Nagy Noémi, Csomor Judit, Berczi Lajos, Varga Viktória, Csóka Monika, Kopper László, Sebestyén Anna, Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study, BMC Cancer, 13, 1, 2013. Crossref

  125. Bai Xueshan, Zhou Weixun, Li Yunhao, Lin Guole, Transanal endoscopic microsurgery with alternative neoadjuvant imatinib for localized rectal gastrointestinal stromal tumor: a single center experience with long-term surveillance, Surgical Endoscopy, 35, 7, 2021. Crossref

  126. Fernandes Michel Ribeiro, Ghezzi Caroline Lorenzoni Almeida, Grezzana-Filho Tomaz JM, Feier Flávia Heinz, Leipnitz Ian, Chedid Aljamir Duarte, Cerski Carlos Thadeu Schmidt, Chedid Marcio Fernandes, Kruel Cléber Rosito Pinto, Giant hepatic extra-gastrointestinal stromal tumor treated with cytoreductive surgery and adjuvant systemic therapy: A case report and review of literature, World Journal of Gastrointestinal Surgery, 13, 3, 2021. Crossref

  127. Shrivastav Anuraag, Murphy Leigh, Interactions of PI3K/Akt/mTOR and estrogen receptor signaling in breast cancer, Breast Cancer Management, 1, 3, 2012. Crossref

  128. Fonseca Daphne, Arya SahithiShilpa, Raju KV. V. N., An unusual occurrence of synchronous gastrointestinal stromal tumor and high-grade serous carcinoma of the endometrium - A rare combination, Muller Journal of Medical Sciences and Research, 11, 2, 2020. Crossref

  129. Jung Kyung-Ho, Lee Jin Hee, Thien Quach Cung Hoa, Paik Jin-Young, Oh Hyunhee, Park Jin Won, Lee Eun Jeong, Moon Seung-Hwan, Lee Kyung-Han, Resveratrol Suppresses Cancer Cell Glucose Uptake by Targeting Reactive Oxygen Species–Mediated Hypoxia-Inducible Factor-1α Activation, Journal of Nuclear Medicine, 54, 12, 2013. Crossref

  130. Wang Jian, Lv Xiaoye, Guo Xiutian, Dong Yanbo, Peng Peipei, Huang Fang, Wang Peng, Zhang Haoqian, Zhou Jianguang, Wang Youliang, Wei Bo, Shang Zeng-Fu, Li Shanhu, Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells, Oncogenesis, 10, 1, 2021. Crossref

  131. Dickson James M. J., Lee Woo-Jeong, Shepherd Peter R., Buchanan Christina M., Enzyme activity effects of N-terminal His-tag attached to catalytic sub-unit of phosphoinositide-3-kinase, Bioscience Reports, 33, 6, 2013. Crossref

  132. Tovell Hannah, Testa Andrea, Zhou Houjiang, Shpiro Natalia, Crafter Claire, Ciulli Alessio, Alessi Dario R., Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader, ACS Chemical Biology, 14, 9, 2019. Crossref

  133. Xiao Qing, Ying Jiayi, Qiao Zhuhui, Yang Yiwen, Dai Xiaoxi, Xu Zhongyi, Zhang Chengfeng, Xiang Leihong, Exogenous hydrogen sulfide inhibits human melanoma cell development via suppression of the PI3K/AKT/ mTOR pathway, Journal of Dermatological Science, 98, 1, 2020. Crossref

  134. Hao Yan-Hui, Zhao Li, Peng Rui-Yun, Effects of microwave radiation on brain energy metabolism and related mechanisms, Military Medical Research, 2, 1, 2015. Crossref

  135. Yu Fei, Cai Ming, Shao Liang, Zhang Jihong, Targeting Protein Kinases Degradation by PROTACs, Frontiers in Chemistry, 9, 2021. Crossref

  136. Wang Caihong, Sun Yalu, Zhao Feng-Qi, Liu Jianxin, Liu Hongyun, Functional Characterization of Peptide Transporters in Bovine Mammary Epithelial Cells, Journal of Agricultural and Food Chemistry, 67, 1, 2019. Crossref

  137. Cardoso Fabrízio dos Santos, Mansur Fernanda Cristina Borini, Lopes-Martins Rodrigo Álvaro Brandão, Gonzalez-Lima Francisco, Gomes da Silva Sérgio, Transcranial Laser Photobiomodulation Improves Intracellular Signaling Linked to Cell Survival, Memory and Glucose Metabolism in the Aged Brain: A Preliminary Study, Frontiers in Cellular Neuroscience, 15, 2021. Crossref

  138. Jia Tao, Zhang Li, Duan Yale, Zhang Min, Wang Gang, Zhang Jun, Zhao Zheng, The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway, Cancer Cell International, 14, 1, 2014. Crossref

  139. Ko Young Hwii, Miyake Hideaki, Behnsawy Hosny M., Cheon Jun, Fujisawa Masato, Limited Significance of Activated Akt-Mammalian Target of Rapamycin Signaling Pathway in Prostate Cancer Progression, Urologia Internationalis, 93, 2, 2014. Crossref

  140. T.G. Shrihari , Chronic Inflammatory Mediators Induced Malignant Changes in Inflammatory Microenvironment of Oral Potentialy Malignant Conditions - An Emerging Concept, Journal of Analytical Oncology, 7, 4, 2018. Crossref

  141. Li Xunjia, Hu Daixing, Li Ying, Luo Yan, Liang Bing, Yu Kexiao, Xiong Weijian, Zuo Deyu, Wang Fu, Overexpression of TP53INP2 Promotes Apoptosis in Clear Cell Renal Cell Cancer via Caspase-8/TRAF6 Signaling Pathway, Journal of Immunology Research, 2022, 2022. Crossref

  142. T.G. Shrihari , Chronic Inflammatory Mediators Induced Malignant Changes in Tumor Microenvironment of Oral Squamous Cell Carcinoma-New Insight , Journal of Analytical Oncology, 7, 4, 2018. Crossref

  143. Li Yong‐Jie, Wang Yue, Wang Yi‐Ying, Retracted : MicroRNA‐99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway , Journal of Cellular Physiology, 234, 6, 2019. Crossref

  144. Wang Haiyan, Cai Shanbao, Ernstberger Aaron, Bailey Barbara J., Wang Michael Z., Cai Wenjing, Goebel W. Scott, Czader Magdalena B., Crean Colin, Suvannasankha Attaya, Shokolenkoc Inna, Wilson Glenn L., Baluyut Arthur R., Mayo Lindsey D., Pollok Karen E., Temozolomide-Mediated DNA Methylation in Human Myeloid Precursor Cells: Differential Involvement of Intrinsic and Extrinsic Apoptotic Pathways, Clinical Cancer Research, 19, 10, 2013. Crossref

  145. Lima Isabel Vieira de Assis, Almeida-Santos Ana Flávia, Ferreira-Vieira Talita Hélen, Aguiar Daniele Cristina, Ribeiro Fabíola Mara, Campos Alline Cristina, de Oliveira Antônio Carlos Pinheiro, Antidepressant-like effect of valproic acid—Possible involvement of PI3K/Akt/mTOR pathway, Behavioural Brain Research, 329, 2017. Crossref

  146. Barati Bagherabad Matineh, Afzaljavan Fahimeh, ShahidSales Soodabeh, Hassanian Seyed Mahdi, Avan Amir, Targeted therapies in pancreatic cancer: Promises and failures, Journal of Cellular Biochemistry, 120, 3, 2019. Crossref

  147. Hou Pengfei, Wang Caihong, Zhou Miaomiao, Liu Hongyun, Properties and regulation of Gly‐Sar uptake and transport in bovine intestinal epithelial cells, Journal of Animal Physiology and Animal Nutrition, 106, 1, 2022. Crossref

  148. Devlin Jennifer R., Hannan Katherine M., Hein Nadine, Cullinane Carleen, Kusnadi Eric, Ng Pui Yee, George Amee J., Shortt Jake, Bywater Megan J., Poortinga Gretchen, Sanij Elaine, Kang Jian, Drygin Denis, O'Brien Sean, Johnstone Ricky W., McArthur Grant A., Hannan Ross D., Pearson Richard B., Combination Therapy Targeting Ribosome Biogenesis and mRNA Translation Synergistically Extends Survival in MYC-Driven Lymphoma, Cancer Discovery, 6, 1, 2016. Crossref

  149. Davis Sally J., Sheppard Karen E., Anglesio Michael S., George Joshy, Traficante Nadia, Fereday Sian, Intermaggio Maria P., Menon Usha, Gentry-Maharaj Aleksandra, Lubinski Jan, Gronwald Jacek, Pearce Celeste Leigh, Pike Malcolm C., Wu Anna, Kommoss Stefan, Pfisterer Jacobus, du Bois Andreas, Hilpert Felix, Ramus Susan J., Bowtell David D.L., Huntsman David G., Pearson Richard B., Simpson Kaylene J., Campbell Ian G., Gorringe Kylie L., Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition, Molecular Cancer Therapeutics, 14, 6, 2015. Crossref

  150. Butler Ethan B., Zhao Yuhua, Muñoz-Pinedo Cristina, Lu Jianrong, Tan Ming, Stalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance, Cancer Research, 73, 9, 2013. Crossref

  151. Sandhöfer N, Metzeler K H, Rothenberg M, Herold T, Tiedt S, Groiß V, Carlet M, Walter G, Hinrichsen T, Wachter O, Grunert M, Schneider S, Subklewe M, Dufour A, Fröhling S, Klein H-G, Hiddemann W, Jeremias I, Spiekermann K, Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia, Leukemia, 29, 4, 2015. Crossref

  152. Yu Le, Wei Jessica, Liu Pengda, Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer, Seminars in Cancer Biology, 2021. Crossref

  153. Pei Xiao-Dong, Yao Hong-Liang, Shen Li-Qun, Yang Yang, Lu Lan, Xiao Jun-Song, Wang Xin-Yu, He Zhi-Long, Jiang Li-He, α-Cyperone inhibits the proliferation of human cervical cancer HeLa cells via ROS-mediated PI3K/Akt/mTOR signaling pathway, European Journal of Pharmacology, 883, 2020. Crossref

  154. Floris Giuseppe, Wozniak Agnieszka, Sciot Raf, Li Haifu, Friedman Lori, Van Looy Thomas, Wellens Jasmien, Vermaelen Peter, Deroose Christophe M., Fletcher Jonathan A., Debiec-Rychter Maria, Schöffski Patrick, A Potent Combination of the Novel PI3K Inhibitor, GDC-0941, with Imatinib in Gastrointestinal Stromal Tumor Xenografts: Long-Lasting Responses after Treatment Withdrawal, Clinical Cancer Research, 19, 3, 2013. Crossref

  155. Muscella Antonella, Cossa Luca Giulio, Vetrugno Carla, Antonaci Giovanna, Marsigliante Santo, ADP sensitizes ZL55 cells to the activity of cisplatin, Journal of Cellular Physiology, 234, 4, 2019. Crossref

  156. Lee Hyo Jae, Seo Ji Won, Kim Sang Hyeon, Lee Chang Yeol, Kim Sang Yong, Kim Young Min, Apoptotic Effects of Butanol Fraction of Lysimachia foenum-graecum by Regulating Akt/mTOR Signaling Pathways in AGS Gastric Cancer Cells, Journal of the Korean Society of Food Science and Nutrition, 51, 3, 2022. Crossref

  157. Li Hui, Wang Jinsong, Yi Zongbi, Li Chunxiao, Wang Haijuan, Zhang Jingyao, Wang Ting, Nan Peng, Lin Feng, Xu Dongkui, Qian Haili, Ma Fei, CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT, European Journal of Cancer, 145, 2021. Crossref

  158. Xing Meng, Wu Bin’e, Wang Shuxia, Heat Shock Protein B7 Inhibits the Progression of Endometrial Carcinoma by Inhibiting PI3K/AKT/mTOR Pathway, Reproductive Sciences, 2022. Crossref

  159. YETKİN Derya, Hidroksizin Hidroklorürün Memeli Makrofajlarında Anti-inflamatuar Aktivitesinin PI3K ve P38 Yolu Üzerinde Araştırılması, Sakarya Medical Journal, 2022. Crossref

  160. Wang Caihong, Chu Chu, Ji Xiang, Luo Guoliang, Xu Chunling, He Houhong, Yao Jianbiao, Wu Jian, Hu Jiangning, Jin Yuanxiang, Biology of Peptide Transporter 2 in Mammals: New Insights into Its Function, Structure and Regulation, Cells, 11, 18, 2022. Crossref

  161. Li Xiaofan, Sun Qi, Ma Wenli, Ma Xinzhe, Pan Hongyue, Guo Wei, Liao Zhijun, Mechanism of Shishiwei Wendan Decoction in the Prevention and Treatment of Lung Adenocarcinoma Using Network Pharmacology and Molecular Docking, BioMed Research International, 2022, 2022. Crossref

  162. Jiang Lin, Zhang Jingbo, Xu Yan, Xu Heng, Wang Mengzhao, Treating non-small cell lung cancer by targeting the PI3K signaling pathway, Chinese Medical Journal, 135, 11, 2022. Crossref

  163. Sulukan Ekrem, Şenol Onur, Baran Alper, Kankaynar Meryem, Yıldırım Serkan, Kızıltan Tuba, Bolat İsmail, Ceyhun Saltuk Buğrahan, Nano-sized polystyrene plastic particles affect many cancer-related biological processes even in the next generations; zebrafish modeling, Science of The Total Environment, 838, 2022. Crossref

2369 文章浏览量 224 文章下载 统计数据
2369 文章浏览量 224 下载次数 163 Crossref 引用次数 Google
Scholar 引用次数

相似内容的文章:

Genomic Alterations to Guide Treatment Selection in Metastatic Prostate Cancer Critical Reviews™ in Oncogenesis, Vol.27, 2022, issue 1
Amy Davies, Arun A. Azad, Edmond M. Kwan
Nitric Oxide and PGE-2 Cross-Talk in EGFR-Driven Epithelial Tumor Cells Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 5-6
Erika Terzuoli, Marina Ziche, Lorenzo Bazzani, Sandra Donnini
Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer Critical Reviews™ in Oncogenesis, Vol.20, 2015, issue 5-6
Diana Marquez-Garban, Yahya Elshimali, Edward B. Garon, Nalo Hamilton, Jaydutt Vadgama, Richard Pietras, David Elashoff, Vei H. Mah
Mechanisms of Metastasis as Related to Receptor Tyrosine Kinases in Small-Cell Lung Cancer Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 3
Patrick C. Ma, Ravi Salgia, Nazia F. Jafri
Strategies to Strike Survival Networks in Cancer Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Marzia Pennati, Giuliana Cassinelli, Graziella Cimino-Reale, Laura Gatti

最新一期

Machine Evaluation of Catchment Area Relevance through Text Mining Philip A. Arlen, Joseph Chakko, Geoffrey DeGennaro, Erin Kobetz, Brandon Mahal Oral Cavity Squamous Cell Carcinoma: Review of Pathology, Diagnosis, and Management Benjamin J. Rich, Stuart E. Samuels, Gregory A. Azzam, Gregory Kubicek, Laura Freedman Surgical Management of the Neck in Oral Cavity Squamous Cell Carcinoma Olivia Mihulka, Eric Nisenbaum, Elizabeth Nicolli Convolutional Neural Networks for Glioma Segmentation and Prognosis: A Systematic Review Janette Herr, Radka Stoyanova, Eric Albert Mellon Proton Beam Therapy for Breast Cancer Seraphina Choi, Isabella Dreyfuss, Crystal Seldon Taswell, Jonathan Cyriac, Michael Butkus, Cristiane Takita Management of Advanced Medullary Thyroid Carcinoma: Current Systemic Therapy Options Mark A. Jara Disparities in Electronic Cigarette Use: A Narrative Review Kyle Edwards, Aysswarya Manoharan, Taghrid Asfar, Samuel Kareff, Gilberto Lopes, Estelamari Rodriguez, Coral Olazagasti The Genetic Paradigm of Hereditary Breast and Ovarian Cancer (HBOC) in the Afro-Caribbean Population Danielle Cerbon, Daphanie Taylor, Priscila Barreto-Coelho, Estelamari Rodriguez, Matthew Schlumbrecht, Judith Hurley, Sophia H.L. George

将发表的论文

Particulate Matter and its impact on Macrophages: Unraveling the cellular response for environmental health Priyanka Priyadarshini Nayayapathi, Gopamma Daka, Srinivas Namuduri, Rama Rao Malla, Suresh Kumar Kolli Neuroplasticity: Pathophysiology and Role in Major Depressive Disorder Rama Rao Malla, Sreeharshini Kadiyala, Priyamvada Bhamidipati IMMUNE EVASION IN CANCER IS REGULATED BY THE TUMOR-ASOCIATED MACROPHAGES (TAMS): TARGETING TAMS Megan Jung, Benjamin Bonavida Disparities in Electronic Cigarette Use: A Narrative Review Kyle Edwards, Aysswarya Manoharan, Taghrid Asfar, Samuel Kareff, Gilberto Lopes, Estelamari Rodriguez, Coral Olazagasti Advanced Medullary Thyroid Carcinoma: The Current Systemic Therapy Options Mark Jara Proton Beam Therapy for Breast Cancer Seraphina Choi, Crystal Taswell, Isabella Dreyfuss, Jonathan Cyriac, Michael Butkus, Cristiane Takita The Genetic Paradigm of Hereditary Breast and Ovarian Cancer in The Afro-Caribbean Population Danielle Cerbon, Daphnie Taylor, Priscila Barreto Coelho, Estelamari Rodriguez, Matthew Schlumbrecht, Judith Hurley, Sophia George
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain